7
Participants
Start Date
June 1, 2021
Primary Completion Date
June 30, 2022
Study Completion Date
June 30, 2022
serology testing profiles description
SARS-CoV-2 quasispecies detection and associated serology testing profiles description (peripheral blood and cerebrospinal fluid - CSF)
immune response characterization
systemic and central immune response characterization , associated to the assessment of CNS damage biomarkers (peripheral blood and CSF)
in vivo brain PET-TSPO acquisitions
in vivo brain PET-TSPO acquisitions (Positon Emission Tomography using a radioligand that targets the Translocator Protein, which is upregulated in activated microglia)
brain MRI assessment
structural/functional brain MRI assessment (PWI/DWI mismatch imaging, quantification of gray and white matter microstructural integrity, DTI, functional connectivity)
neurocognitive assessment
multi-domains neurocognitive assessment
University Hospital of Toulouse, Toulouse
CHRU Tours, Tours
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
University Hospital, Toulouse
OTHER